Fili Natalia, Hari-Gupta Yukti, Aston Bjork, Dos Santos Ália, Gough Rosemarie E, Alamad Bana, Wang Lin, Martin-Fernandez Marisa L, Toseland Christopher P
Sheffield Cancer Centre, Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2RX, United Kingdom.
School of Biosciences, University of Kent, Canterbury CT2 7NZ, United Kingdom.
J Biol Chem. 2020 Jan 10;295(2):337-347. doi: 10.1074/jbc.RA119.010142. Epub 2019 Nov 19.
Myosin VI is involved in many cellular processes ranging from endocytosis to transcription. This multifunctional potential is achieved through alternative isoform splicing and through interactions of myosin VI with a diverse network of binding partners. However, the interplay between these two modes of regulation remains unexplored. To this end, we compared two different binding partners and their interactions with myosin VI by exploring the kinetic properties of recombinant proteins and their distribution in mammalian cells using fluorescence imaging. We found that selectivity for these binding partners is achieved through a high-affinity motif and a low-affinity motif within myosin VI. These two motifs allow competition among partners for myosin VI. Exploring how this competition affects the activity of nuclear myosin VI, we demonstrate the impact of a concentration-driven interaction with the low-affinity binding partner DAB2, finding that this interaction blocks the ability of nuclear myosin VI to bind DNA and its transcriptional activity We conclude that loss of DAB2, a tumor suppressor, may enhance myosin VI-mediated transcription. We propose that the frequent loss of specific myosin VI partner proteins during the onset of cancer leads to a higher level of nuclear myosin VI activity.
肌球蛋白VI参与从内吞作用到转录等许多细胞过程。这种多功能潜力是通过可变剪接异构体以及肌球蛋白VI与各种结合伙伴网络的相互作用实现的。然而,这两种调节模式之间的相互作用仍未得到探索。为此,我们通过研究重组蛋白的动力学特性及其在哺乳动物细胞中的分布,利用荧光成像比较了两种不同的结合伙伴及其与肌球蛋白VI的相互作用。我们发现,对这些结合伙伴的选择性是通过肌球蛋白VI内的一个高亲和力基序和一个低亲和力基序实现的。这两个基序允许伙伴之间竞争肌球蛋白VI。通过探索这种竞争如何影响核肌球蛋白VI的活性,我们证明了与低亲和力结合伙伴DAB2的浓度驱动相互作用的影响,发现这种相互作用会阻断核肌球蛋白VI结合DNA的能力及其转录活性。我们得出结论,肿瘤抑制因子DAB2的缺失可能会增强肌球蛋白VI介导的转录。我们提出,在癌症发生过程中特定肌球蛋白VI伙伴蛋白的频繁缺失会导致核肌球蛋白VI活性水平升高。